References
- Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol 2011;46:324-47. https://doi.org/10.1002/ppul.21377
- Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med 2002;96 Suppl B:S1-7. https://doi.org/10.1016/S0954-6111(02)90076-4
- Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J Pediatr 2003;143:S112-7. https://doi.org/10.1067/S0022-3476(03)00508-0
- De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21. https://doi.org/10.1086/588660
- Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Gleaves CA, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992;165:987-93. https://doi.org/10.1093/infdis/165.6.987
- Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, et al. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia. Haematologica 2007;92:1216-23. https://doi.org/10.3324/haematol.11300
- Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986;315:77-81. https://doi.org/10.1056/NEJM198607103150201
- El Saleeby CM, Somes GW, DeVincenzo JP, Gaur AH. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age. Pediatrics 2008;121:235-43. https://doi.org/10.1542/peds.2007-1102
- Raboni SM, Nogueira MB, Tsuchiya LR, Takahashi GA, Pereira LA, Pasquini R, et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003;76:142-6. https://doi.org/10.1097/01.TP.0000072012.26176.58
- Groothuis JR, Woodin KA, Katz R, Robertson AD, McBride JT, Hall CB, et al. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children. J Pediatr 1990;117:792-8. https://doi.org/10.1016/S0022-3476(05)83347-5
- Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med 1983;308:1443-7. https://doi.org/10.1056/NEJM198306163082403
- Shults RA, Baron S, Decker J, Deitchman SD, Connor JD. Health care worker exposure to aerosolized ribavirin: biological and air monitoring. J Occup Environ Med 1996;38:257-63. https://doi.org/10.1097/00043764-199603000-00010
- Anak S, Atay D, Unuvar A, Garipardic M, Agaoglu L, Ozturk G, et al. Respiratory syncytial virus infection outbreak among pediatric patients with oncologic diseases and/or BMT. Pediatr Pulmonol 2010;45:307-11.
- Raza K, Ismailjee SB, Crespo M, Studer SM, Sanghavi S, Paterson DL, et al. Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant 2007;26:862-4. https://doi.org/10.1016/j.healun.2007.05.020
- Sparrelid E, Ljungman P, Ekelof-Andstrom E, Aschan J, Ringden O, Winiarski J, et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997;19:905-8. https://doi.org/10.1038/sj.bmt.1700752
- Hasejima N, Yamato K, Takezawa S, Kobayashi H, Kadoyama C. Invasive pulmonary aspergillosis associated with influenza B. Respirology 2005;10:116-9. https://doi.org/10.1111/j.1440-1843.2005.00593.x
- Alba D, Gomez-Cerezo J, Cobo J, Ripoll MM, Molina F, Vazquez JJ. Invasive pulmonary aspergillosis associated with influenza virus. An Med Interna 1996;13:34-6.
- Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002;100:4358-66. https://doi.org/10.1182/blood-2002-05-1496
- Martino R, Pinana JL, Parody R, Valcarcel D, Sureda A, Brunet S, et al. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 2009;44:749-56. https://doi.org/10.1038/bmt.2009.78